07 Jan 2001

MCP Hexal® (MCP Hexal® 10 Tabletten) - Deutschland

Updated: 07 Jan 2001

MCP Hexal® 10; -Tropfen; -injekt

Motilitätsstör. des oberen Magen-Darmtraktes. Übelkeit u. Erbrechen, Brechreiz. Zusätzlich bei Inj.-lsg.: z. Erleichterung der Duodenal- u. Jejunalsondierung. Beschleunigung der Magenentleerung und Dünndarmpassage bei d. röntgenologischen Untersuchung.

MCP Hexal® Description, Presentation and Dosage

MCP Hexal® Description

MCP Hexal® Drug Class Description

Einzelstoffe

MCP Hexal® Drug Description

1 Tbl. enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).

MCP Hexal® Generic Name

MCP Hexal® 10 Tabletten

MCP Hexal® Presentation

MCP Hexal® Presentation

MCP Hexal® 10; -Tropfen; -injekt

MCP Hexal® Manufacturer

Hexal

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

MCP Hexal® Dosage

MCP Hexal® Adult Dosage

Calciumhydrogenphosphat, Lactose, Magnesiumstearat, Poly(O-carboxymethyl)stärke-Natrium, Maisstärke, Siliciumdioxid. ger. Wasser.

MCP Hexal® Child Dosage


MCP Hexal® Tropfen
Zus.: 1 ml (ca. 15 Tr.) enth.: Metoclopramid-HCl 1H2O 4,21 mg (entspr. 3,56 mg Metoclopramid bzw. 4 mg Metoclopramid-HCl).
Weit. Bestandteile: Methyl-4-hydroxybenzoat 1,3 mg, Propyl-4-hydroxybenzoat 0,2 mg, Natriumcyclamat, Natriumdihydrogenphosphat, Natriummetabisulfit, Saccharin-Natrium,

MCP Hexal® injekt Injektionslösung
Zus.: 1 Amp. (2 ml) enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).
Weit. Bestandteile: Natriumchlorid, Wasser f. Inj.-zwecke.

MCP Hexal® Precautions, Reactions and Contraindications

MCP Hexal® Special Precautions

MCP Hexal® Special Precautions

D 70 a-f, Z 3. Säugl. u. Kleinkdr. bis 2 J.

MCP Hexal® Adverse Reactions

MCP Hexal® Adverse Reactions

D 70

Related Drugs - Gastroenterology

Back to top